Riding an endless wave of nostalgia, one company is exhuming the intellectual property of midcentury designers to create new ...

The Company had previously announced that it was notified by Nasdaq on December 4, 2025, that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550 (a) ...

This article explores three critical fronts shaping the future of IP: federal AI legislation and executive preemption, ...

An explanation of the legal issues surrounding consumer sales promotions, specifically prize and price promotions, highlighting sweepstakes, contests, discounts, price comparisons, free offers, ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and ...

Giving glove materials a verifiable “memory” to support safe recovery, traceability, and circular reuse NEW YORK, NY / ACCESS Newswire / December 31, 2025 / SMX (Security Matters) PLC (NASDAQ:SMX; ...

Proceeds to Support the Company’s Assessment of Opportunities to Advance BX011 and Ongoing Evaluation of Strategic ...

Giving Materials Memory” enables denim to be authenticated, traced & reintroduced as a higher-value, verifiable input for reuse and recycling NEW YORK CITY, NEW YORK / ACCESS Newswire / December 30, ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

Forty years ago I forecast that the impact of machine learning would be that book-learning and logical reasoning would lose status just as literacy did when everyone could read and write. Two years ...